Add like
Add dislike
Add to saved papers

Neurobehavioral and Medical Correlates of Autism Screening: 2-Year Outcomes for Infants Born Very Preterm.

OBJECTIVES: To identify neonatal characteristics and 2-year neurodevelopmental outcomes associated with positive screening for risk of autism.

STUDY DESIGN: Nine university-affiliated neonatal intensive care units (NICUs) enrolled infants born at <30 weeks of gestation. Infants underwent the NICU Network Neurobehavioral Scale (NNNS) examination before discharge and the Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-III), the Child Behavior Checklist (CBCL), and the Modified Checklist for Autism in Toddlers, revised with follow-up (M-CHAT-R/F) at two years corrected age. Generalized estimating equations examined associations between M-CHAT-R/F, neurobehavioral test results, and neonatal medical morbidities.

RESULTS: At two years corrected age, data were available for 466/744 enrolled infants without cerebral palsy. Infants with hypo-aroused NNNS profiles were more likely to screen M-CHAT-R/F positive (OR=2.76, 95% CI: 1.38, 5.54).). Infants with ≥ 2 medical morbidities also were more likely to screen positive (OR=2.65, 95% CI: 1.27, 5.54).). Children with positive M-CHAT-R/F scores had lower Bayley-III Cognitive (t (451)=5.43, p < .001, d=0.82), Language (t (53.49)= 7.82, p < .001, d=1.18), and Motor (t (451)=7.98, p < .001, d=1.21) composite scores and significantly higher CBCL Internalizing (t (457) -6.19, p < .001, d=-0.93) and Externalizing (t (57.87)=-5.62, p < .001, d=-0.84) scores.

CONCLUSIONS: Positive M-CHAT-R/F screens at 2 years corrected age were associated with neonatal medical morbidities and neurobehavioral examinations as well as toddler developmental and behavioral outcomes. These findings demonstrate the potential utility of the M-CHAT-R/F as a global developmental screener in infants born very preterm, regardless of whether there is a later autism diagnosis.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app